Title |
A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy
|
---|---|
Published in |
Frontiers in Medicine, July 2018
|
DOI | 10.3389/fmed.2018.00184 |
Pubmed ID | |
Authors |
Sally H. Ibbotson |
Abstract |
Narrowband UVB (NB-UVB) phototherapy and psoralen-UVA (PUVA) photochemotherapy are widely used phototherapeutic modalities for a range of skin diseases. The main indication for NB-UVB and PUVA therapies is psoriasis, and other key diagnoses include atopic eczema, vitiligo, cutaneous T-cell lymphoma (CTCL), and the photodermatoses. The decision on choice of phototherapy is important and NB-UVB is usually the primary choice. NB-UVB phototherapy is a safe and effective therapy which is usually considered when topical agents have failed. PUVA requires prior psoralen sensitization but remains a highly effective mainstay therapy, often used when NB-UVB fails, there is rapid relapse following NB-UVB or in specific indications, such as pustular or erythrodermic psoriasis. This review will provide a perspective on the main indications for use of NB-UVB and PUVA therapies and provide comparative information on these important dermatological treatments. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 97 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 14 | 14% |
Student > Bachelor | 12 | 12% |
Student > Postgraduate | 8 | 8% |
Student > Ph. D. Student | 6 | 6% |
Student > Doctoral Student | 5 | 5% |
Other | 13 | 13% |
Unknown | 39 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 33% |
Nursing and Health Professions | 4 | 4% |
Chemistry | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Agricultural and Biological Sciences | 2 | 2% |
Other | 10 | 10% |
Unknown | 43 | 44% |